Published in Ocular Surface

Dry Eye Disease: Our Latest Insights for Improved Outcomes

This is editorially independent content supported by advertising from Bausch + Lomb
7 min read

Join Drs. Barnett and Quint to review practical strategies for optometrists to incorporate dry eye diagnostics and targeted therapies into their practice

In this episode of Inside Intrepid, Melissa Barnett, OD, FAAO, FSLS, FBCLA, and Jessilin Quint, OD, MBA, FAAO, discuss simple yet effective strategies to improve outcomes for patients with dry eye disease (DED). The tips they share may help clinicians diagnose the condition earlier, improve long-term treatment outcomes, and support practice growth.
Dr. Barnett is a world-renowned optometrist and public speaker. She’s one of the foremost experts in the treatment of dry eye disease and has special interests in keratoconus, presbyopia, and specialty contact lenses. Dr. Quint is a board-certified optometrist and public speaker. She’s the co-owner of Smart Eye Care, which has offices in Bangor, Augusta, and Farmingdale, Maine. Like Dr. Barnett, Dr. Quint has special interests in specialty contact lenses and dry eye disease.

I like to rule out dry eye [for] every single patient. We see dry eye in eight-year-olds; we see dry eye in 80-year-olds. Dry eye is so common, and years ago, we didn’t have any treatment options.

DED fast facts

  • Dry eye disease is very common, and every patient should be screened for it.
  • Early diagnosis allows for quicker treatment, lowering the risk of permanent ocular surface changes.
  • Patient education is one of the best and most effective ways to improve treatment outcomes.
  • Every patient experiences dry eye differently. As a result, successful treatment requires personalized care tailored to the individual.
  • Dry eye screenings can be integrated into clinical workflows to improve patient care and support practice growth.

Deeper dive: Insights for improved outcomes in DED

Dr. Barnett and Dr. Quint discussed how much screening and treatment protocols for DED have changed since they first started practicing.
Not so long ago, the condition was associated with middle-aged women and older individuals, but advances in research have shown that DED affects people of all ages,1 and early diagnosis and treatment can help slow its progression and improve outcomes.
Perhaps most important, though, is building long-term partnerships and meeting dry eye patients where they’re at. DED isn’t a one-time diagnosis, and cultivating lasting relationships can benefit those in your care and your practice.

Identify dry eye earlier

Dry eye disease affects approximately 16 million Americans, with some experts estimating the number to be 30 million or even higher. However, studies have found that a significant proportion of patients with DED may be asymptomatic. In one study, approximately 24.1% of participants with signs of the condition reported no obvious symptoms.2
Consequently, DED is often underdiagnosed and overlooked. Even when DED presents symptoms, patients may attribute them to outside sources such as fatigue or allergies. To ensure patients with dry eyes receive the best possible treatment, Dr. Barnett and Dr. Quint argue for DED screening as early as possible, even if it isn’t the primary reason for a visit.
Specifically, they recommend using resources such as diagnostic recommendations from the Tear Film & Ocular Surface Society (TFOS), the Ocular Surface Disease Index (OSDI) questionnaire, and the Standard Patient Evaluation of Eye Dryness (SPEED) questionnaire to identify DED early and initiate appropriate treatment.

For a deeper dive into evidence-based approaches to diagnosing and managing DED, check out What Optometrists Need to Know About TFOS DEWS III with Cheat Sheet!

Setting expectations improves outcomes

Diagnosing DED is only half the battle. Helping patients adhere to their treatment plans is equally important for achieving long-term symptom relief. Research suggests that improving patient knowledge and attitudes through education may help strengthen adherence, particularly among patients in later stages of their treatment course.3

I start [by explaining] that dry eye is a chronic condition, and that this is a process. I like to talk about short-term relief and long-term relief: these are the things that we’re going to do right now to make you feel better faster, and these are the things that we’re going to do over time.

Since some patients find a DED diagnosis overwhelming, it’s important to meet each individual where they’re at. One of the best ways to do that is by presenting information in easily digestible formats.
Some effective approaches include:
  • Walking patients through the results of their imaging tests, such as corneal topography and infrared meibography
  • Sharing informational brochures and/or one-page resources about DED
  • Explaining the underlying factors contributing to each patient’s DED diagnosis
Dr. Barnett and Dr. Quint also recommend breaking treatment down into stages, with a focus on managing each underlying cause as part of a comprehensive treatment plan.
As Dr. Quint explains: "To really [help a patient] get better, we have to address all those underlying root causes. I usually break treatment down into phases—phase one, phase two, phase three—and map that out for patients. I send them home with an overview of what I saw, our treatment plan, what we’re starting with, and what we’ll likely address in the future."

How to incorporate dry eye care into your practice

Evaluating all patients for DED is an effective way to diagnose and treat the condition earlier. However, many ophthalmologists and optometrists worry they need specialized diagnostics or other equipment to add this service to their practice offerings.
The good news is that clinicians don’t need every available tool to improve DED detection and management. Dr. Quint and Dr. Barnett both noted that incorporating dry eye care into practice only requires a few simple resources.
These may include:

Some docs are a little intimidated to get into this space because they think that you have to purchase all this fancy equipment. It's fun to have, it’s helpful, and it serves a big role, but you can still treat dry eye and serve your patients with … the basics.

Even using just a handful of these diagnostic tools can help you detect DED earlier and provide additional benefit to your patients.

Lifestyle still matters

Comprehensive management of DED also requires clinicians to understand the environmental and lifestyle factors that can contribute to its symptoms. Although prescription medications and artificial tears can often reduce dry eye-related discomfort, addressing underlying factors that contribute to symptoms can help support more comprehensive management.
Dr. Barnett and Dr. Quint recommend asking your patients questions about several lifestyle factors, in particular, including:
It’s also important to consider a patient’s overall health history, including any autoimmune diseases, as these conditions may affect tear production and contribute to DED.4
As the industry’s understanding of DED continues to evolve, successful management requires clinicians to address more than symptoms alone. DED is a chronic condition influenced by a variety of factors, including underlying medical issues as well as lifestyle factors.

Take home

This complexity means there’s no one-size-fits-all treatment solution. However, the providers who partner with their patients early to screen for and diagnose DED can help improve outcomes.
It’s important to remember that symptom relief is only part of the goal. The right treatment approach will also focus on restoring ocular surface health and improving quality of life.

Dry eye is … multifactorial. There are several underlying causes … and to really get [patients] better, we have to address all those underlying root causes.

  1. Barabino S. Is dry eye disease the same in young and old patients? A narrative review of the literature. BMC Ophthalmol. 2022 Feb 22;22:85. doi:10.1186/s12886-022-02269-2
  2. Shah S, Jani H. Prevalence and associated factors of dry eye. Oman J Ophthalmol. 2015;8(3):151-156. doi: 10.4103/0974-620X.169910
  3. Xu W, Gu S, Li W, Yin L. Knowledge, attitudes, and practices towards dry eye disease treatment among patients: a cross-sectional study. BMC Public Health. 2026 Jan 13;26:532. doi: 10.1186/s12889-025-26151-0
  4. Chen NN, Huang YT, Sun CC. Epidemiology of Dry Eye in Patients With Autoimmune Disease. JAMA Network Open. 2026;9(2):e2560275. doi:10.1001/jamanetworkopen.2025.60275
Melissa Barnett, OD, FAAO, FSLS, FBCLA
About Melissa Barnett, OD, FAAO, FSLS, FBCLA

Dr. Melissa Barnett is a principal optometrist at the University of California, Davis Eye Center in Sacramento and Davis, California. She is an internationally recognized key opinion leader, specializing in dry eye disease and specialty contact lenses. Dr. Barnett lectures and publishes extensively on topics including dry eye, anterior segment disease, contact lenses and creating a healthy balance between work and home life for women in optometry. She is a Fellow of the American Academy of Optometry, a Diplomate of the American Board of Certification in Medical Optometry, a Fellow of the British Contact Lens Association and serves on the Board of the American Optometric Association Contact Lens and Cornea Section, Gas Permeable Lens Institute, International Society of Contact Lens Specialists and is Past President of The Scleral Lens Education Society.

Drs. Melissa Barnett and Lynette Johns authored and edited the book Contemporary Scleral Lenses: Theory and Application with the unique perspectives and contributions of international experts. Dr. Barnett was awarded the inaugural Theia Award for Excellence for Mentoring by Women in Optometry. She was granted the Most Influential Women in Optical from Vision Monday in 2019.

In her spare time, she enjoys cooking, yoga, hiking and spending time with her family, Todd Erickson, also an optometrist, and two sons, Alex and Drew.

To learn more, visit her website at: www.drmelissabarnett.com

Melissa Barnett, OD, FAAO, FSLS, FBCLA
Jessilin Quint, OD, MS, MBA, FAAO
About Jessilin Quint, OD, MS, MBA, FAAO

Dr. Quint graduated from Baylor University with a Bachelor of Arts (BA) degree in Biology. She completed both Master in Business Administration (MBA) and a Master of Science (MS) in Molecular Biology degrees at West Texas A&M University. She graduated from Indiana University with a Doctorate of Optometry (OD) degree and completed a post-doctoral Residency in Ocular Disease and Trauma at the Illinois Eye Institute in Chicago.

She is a Fellow of the American Academy of Optometry and a Board-Certified Diplomate of the American Board of Optometry. She is an active volunteer, speaker, and author in many industry publications. Her passion for dry eye led her to pursue advanced dry eye training all over the United States, and she is excited to bring that skillset to Central Maine. Additionally, her extensive knowledge regarding Dry Eye Disease has also led her to consult for many international pharmaceutical and beauty companies.

Jessilin Quint, OD, MS, MBA, FAAO
💙 Inside Intrepid
Orasis Pharmaceuticals
Bausch + Lomb Xiidra
Bausch + Lomb Miebo
TenPoint - Yuvezzi